Oshen Bio

Oshen Bio (operating as Oshen Holdings SA) is a European-based family office founded in 2022 and headquartered in Switzerland, with an additional presence in Luxembourg. The firm invests in biotech and medtech life sciences companies focused on improving quality of life as people age — a thesis it calls 'Better Ageing.' It operates as an evergreen investment vehicle, meaning it is not bound by fixed fund horizons or mandated investment structures, and invests across a broad spectrum from early-stage to market-ready companies. Oshen targets IP-rich businesses with patent-protected technologies and partners with leading scientific institutions globally to provide portfolio companies with strategic value and market access. Known investments include Healome Therapeutics, Scarlet Therapeutics, 4D Medicine, and Topadur Pharma. The firm is led by three Managing Partners — Didier Cowling (Switzerland), Justin Cahill (Ireland), and Peter Wang — who bring backgrounds spanning life sciences, corporate finance, and international business.